-->
Search for Clinical Trial Results

Explore a wide range of ongoing clinical trials and research studies. Stay updated on the latest healthcare advancements and medical breakthroughs. Learn how you can participate in medical research to contribute to scientific progress

Adenoid Cystic Carcinoma - 106 Studies Found

Status Study
Not yet recruiting Study Name: Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer
Condition: Major Salivary Gland Carcinoma Minor Salivary Gland Carcinoma
Date: 2017-05-05
Interventions: Biological: Ipilimumab Given I
Recruiting Study Name: Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Condition: Adenoid Cystic Carcinoma
Date: 2017-03-13
Interventions: Radiation: Radiation Standard
Not yet recruiting Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Condition: Adenoid Cystic Carcinoma Adnexal Carcinoma
Date: 2016-11-30
Interventions: Other: Laboratory Biomarker Analysis
Not yet recruiting Study Name: Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
Condition: Adenoid Cystic Carcinoma
Date: 2016-10-18
Interventions: Drug: Apatinib Apatinib will b
Not yet recruiting Study Name: Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
Condition: Adenocystic Carcinoma
Date: 2016-08-25
Interventions: Drug: Chidamide Other Name: epidaza
Active, not recruiting Study Name: Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14
Condition: Adenoid Cystic Carcinomas of the Salivary Glands
Date: 2016-08-02
Interventions: Drug: Lenvatinib Lenvatinib will be self orally administered at 24 mg daily, on a continuous basis in 4
Recruiting Study Name: Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma
Condition: Recurrent ACC, metastaticACC, Unreaectable ACC
Date: 2016-07-28
Interventions: Drug: Axitinib Dosing schedule
Not yet recruiting Study Name: Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
Condition: Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Date: 2016-07-18
Interventions: Radiation: Carbon ions therapy
Recruiting Study Name: Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
Condition: Adenoid Cystic Carcinoma
Date: 2016-05-19
Interventions: Drug: Lenvatinib
Recruiting Study Name: A Study of Apatinib in Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Condition: Adenoid Cystic Carcinoma
Date: 2016-05-12
Interventions: Drug: Apatinib Mesylate Apatinib Mesylate will be administered orally at 500 mg once daily for 5 consecu
Page 1 of 11
Next >>>